A Randomized, Placebo-controlled, Double-blind, Dose-escalation Phase I Study of the Safety, Tolerability and Pharmacokinetics of a Single Intravenous Dose of ETI-204 (AnthimTM) (AH-102)

Authors

Jeffrey L. Huston, Cedarville UniversityFollow

Role

Lead Pharmacist

Sponsor

Elusys Pharmaceuticals

Location

Pine Brook, NJ

Recommended Citation

Huston, Jeffrey L., "A Randomized, Placebo-controlled, Double-blind, Dose-escalation Phase I Study of the Safety, Tolerability and Pharmacokinetics of a Single Intravenous Dose of ETI-204 (AnthimTM) (AH-102)" (2009). Pharmacy Faculty Research. 22.
https://digitalcommons.cedarville.edu/pharmacy_research/22